@article{TAU19629,
author = {Ross A. Avant and Cameron M. Charchenko and Manaf Alom and Mary E. Westerman and Francisco Maldonado and Tanner Miest and Landon Trost},
title = {Medication patterns and fertility rates in a cohort of anabolic steroid users},
journal = {Translational Andrology and Urology},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Background: To describe self-reported medication patterns and fertility rates in a population of anabolic steroid (AS) users.
Methods: We reviewed data from an online survey of AS users and identified a sub-group who had attempted to achieve a pregnancy with their partners while using AS. The online survey consisted of questions addressing demographics, AS use, ancillary medications, and fertility outcomes.
Results: A total of 97 men (of 231 total respondents) had attempted to achieve a pregnancy while taking AS and comprise the current cohort. The majority of men were 25–44 years old (63.9%), married (75.5%) and Caucasian (88.7%). Ancillary drug use was common with only 5.2% denying drug use other than ASs. The most common reported ancillary drugs were antiestrogens (89.7%) and sexual enhancement medications (SEMs) (68%). The fertility rate was 92.8%, with 82.4% achieving pregnancy within one year. Interestingly, only 13.5% sought fertility evaluation with treatment required in 8.3%. Age at initiation of AS use, maximum dosage utilized, yearly duration of supplementation, and number of years using steroids were not associated with a prolonged duration to pregnancy or decreased rate of pregnancy.
Conclusions: Despite continued use of ASs, this cohort’s self-reported fertility rates are unexpectedly high. This is presumably related to cycling of therapy and concomitant use of fertility preserving medications.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/19629}
}